HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amazon Testing Update Could, As FDA And Industry Want, Purge Bad Actors From Supplement Market

Executive Summary

Latest update to Amazon’s screening policy for supplements requires showing sexual enhancement and weight loss products have been tested by third-party labs and lays out additional requirements for all supplement products.

You may also be interested in...



Amazon Response About Drug-Spiked Supplements ‘Not Sufficient To Protect Public’ – FDA

“Amazon has taken some action when alerted by the FDA about sales” of violative supplements, but FDA "found that other such products continue to be offered for sale” by the firm through its Fulfillment by Amazon service, according to untitled letter.

Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements

Amazon requires firms selling supplements on its site in the US to demonstrate their products comply with FDA regulations for labeling and GMPs. Marketers that don’t submit documentation face removal of their products from the site.

SSCI Offers Benchmarks As Gatekeepers For Supplements To Reach Retail Shelves

FDA’s GMP final rule set uniform standards to ensure quality throughout manufacturing, packaging, labeling and holding of supplements, but Supplement Safety and Compliance Initiative says manufacturing practices continue to vary widely across the industry and the agency cannot inspect every facility. “FDA can’t solve all our problems. I don’t know if FDA knows the number of facilities it needs to inspect to ensure consumer confidence," says Daniel Fabricant, president of SSCI member NPA.

Topics

UsernamePublicRestriction

Register

RS151952

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel